60 DEGREES PHARMACEUTICALS, INC. - Annual Financials - Income Statement (SEC)

Updated on January 2, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

60 DEGREES PHARMACEUTICALS, INC. - Annual Income Statement (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31
Product Revenues net of Discounts and Rebates	607.574	253.573
Cost of Revenues	384.765	474.55
Gross Profit (Loss)	222.809	-220.977
Research Revenues	73.771	0
Net Revenue (Loss)	296.58	-220.977
Research and Development	4986.526	691.77
General and Administrative Expenses	5024.985	4241.836
Total Operating Expenses	10011.511	4933.606
Loss from Operations	-9714.931	-5154.583
Interest Expense	7.912	2286.637
Derivative Expense	0	-399.725
Change in Fair Value of Derivative Liabilities	-1665.966	37.278
Loss on Debt Extinguishment	0	-1231.48
Change in Fair Value of Promissory Note	0	5379.269
Other Income (Expense), net	101.464	-83.116
Total Interest and Other Income (Expense), net	1759.518	1341.033
Total Loss before Income Taxes	-7955.413	-3813.55
Provision for Income Taxes (Note 9)	0.25	0.25
Net Loss including Noncontrolling Interest	-7955.663	-3813.8
Net Loss Noncontrolling Interest	-8.556	-48.098
Net Loss attributed to 60 Degrees Pharmaceuticals, Inc.	-7947.107	-3765.702
Net Loss	-7955.663	-3813.8
Unrealized Foreign Currency Translation (Loss) Gain	-0.09	61.853
Total Comprehensive Loss	-7955.753	-3751.947
Net Loss Noncontrolling Interest	-8.556	-48.098
Comprehensive Loss attributed to 60 Degrees Pharmaceuticals, Inc.	-7947.197	-3703.849
Cumulative Dividends on Series A Preferred Stock	483.301	220.714
Net Loss - attributed to common stockholders	-8430.498	-3924.563
Basic Earnings Per Share	-18.55	-59.18
Diluted Earnings Per Share	-18.55	-59.18
Basic Weighted Average Shares Outstanding	454.582	66.314
Diluted Weighted Average Shares Outstanding	454.582	66.314